Cosimo Ottomano

Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging

Pleiotropic effects of type 2 diabetes management strategies on renal risk factors

Fourth Universal Definition of Myocardial Infarction (2018)

Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?

Inflammation and Cancer: Triggers, Mechanisms, and Consequences

The Binary Classification of Protein Kinases

The Oslo definitions for coeliac disease and related terms

Cutting-Edge Issues in Celiac Disease and in Gluten Intolerance

How to use high-sensitivity cardiac troponins in acute cardiac care

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

Third Universal Definition of Myocardial Infarction

Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Approach to patients with essential thrombocythaemia and very high platelet counts: what is the evidence for treatment?

Effects of fenofibrate on lipids, lipoproteins, and apolipoproteins in 33 subjects with primary hypercholesterolemia

Diversity, Mechanisms, and Significance of Macrophage Plasticity

PTX3, a Humoral Pattern Recognition Molecule, in Innate Immunity, Tissue Repair, and Cancer

Fourth Universal Definition of Myocardial Infarction (2018)

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Fourth universal definition of myocardial infarction (2018)

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.

Innate immunity, inflammation and tumour progression: double‐edged swords

Evaluation of analytical performance of the Pathfast® cardiac troponin I

IgA anti-actin antibodies ELISA in coeliac disease: A multicentre study

Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3

JAK2V617F mutation and hydroxyurea treatment as determinants of immature platelet parameters in essential thrombocythemia and polycythemia vera patients

Fenofibrate therapy of hypertriglyceridaemias. Differential effects on LDL cholesterol level in Type IV and in Type IIb primary hyperlipoproteinaemia

Renal and Metabolic Effects of Insulin Lispro in Type 2 Diabetic Subjects With Overt Nephropathy